Welsis Corp. (WLSS)
About Welsis Corp.
WELSIS CORP
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $0
- Net income
- -$60.7K
- Total assets
- $2.2K
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Welsis Corp. (WLSS) Stock Price
- Reported a net loss of $60.7K in FY2025.
- Trading 46% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Welsis Corp..
Write a review
Welsis Corp.: frequently asked questions
Is Welsis Corp. an American company?
Welsis Corp. is a US-based company headquartered in Philadelphia, Pennsylvania, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Welsis Corp. headquartered?
Welsis Corp. is headquartered in Philadelphia, Pennsylvania, United States.
Is Welsis Corp. publicly traded?
Yes — Welsis Corp. is a publicly traded company. Its stock trades under the ticker symbol WLSS on the OTC.
What does Welsis Corp. do?
Welsis Corp. is an American Medical Devices company in the Health & Beauty sector.
